[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353157-105":59,"doc-detail-353157-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeted-metabolomic-profiling-of-gastric-cancer-biopsies","Targeted metabolomic profiling of gastric cancer biopsies","","Gastric cancer shows high metabolic activity and marked heterogeneity, yet diagnosis lacks disease-specific serum biomarkers. This study performs targeted metabolomic profiling of gastric cancer biopsies collected via esophagogastroduodenoscopy in a South Indian cohort using LC–MS. MetaboAnalyst 6.0 supports pathway enrichment, univariate testing, and ROC-based biomarker evaluation across tumor, paired normal, and normal mucosa samples. Distinct metabolic shifts implicate amino acid, pyrimidine, nucleotide, arginine, and one-carbon metabolism. Ornithine and citrulline emerge as potential diagnostic biomarkers and therapeutic targets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeted-metabolomic-profiling-of-gastric-cancer-biopsies/353157/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeted-metabolomic-profiling-of-gastric-cancer-biopsies/353157.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main objective in gastric cancer research?","Question",{"text":113,"@type":114},"To identify distinct metabolic alterations in gastric cancer biopsies using targeted metabolomic profiling and evaluate potential biomarkers and affected pathways.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were metabolites analyzed in this research?",{"text":118,"@type":114},"Metabolites were profiled using liquid chromatography–mass spectrometry (LC–MS), followed by pathway enrichment, univariate analysis, and ROC curve assessment with MetaboAnalyst 6.0.",{"name":120,"@type":111,"acceptedAnswer":121},"Which metabolites are highlighted as potential diagnostic biomarkers?",{"text":122,"@type":114},"Ornithine and citrulline are identified as potential discriminators for distinguishing gastric cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353157,1790145853,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Indian J Med Res 163, June 2026, pp 710-719 DOI: 10.25259/IJMR_3386_2025  \nOriginal Article  \nTargeted metabolomic profiling of gastric cancer biopsies  \nAathithya Rangarajan,1 Thirumoorthi Natarajan,2 Sujatha Lakshminarayanan,2 Shirley Sundersingh,3 Jayavelu Subramani1 and Gopal Gopisetty1  \nDepartments of 1Molecular Oncology, 2Medical Gastroenterology, and 3Oncopathology, Cancer Institute (WIA), Chennai, TamilNadu, India  \nReceived December 3, 2025; Accepted January 19, 2026; Published June 10, 2026  \nBackground and objectives: Gastric cancer, the fifth most diagnosed malignancy worldwide and seventh in India, exhibits high metabolic activity and marked heterogeneity. In this study, we performed targeted metabolomic profiling of gastric cancer biopsies obtained through esophagogastroduodenoscopy in a South Indian cohort.  \nMethods: Targeted metabolite profiling was conducted using liquid chromatography–mass spectrometry (LC–MS) analysis. Pathway enrichment and biomarker evaluation were performed using MetaboAnalyst 6.0, incorporating univariate analysis and receiver operating characteristic (ROC) curve assessment.  \nResults: LC-MS based analysis of tumour (n=25), paired normal (n=25), and normal gastric mucosa (n=3) samples revealed distinct metabolic alterations associated with gastric cancer. The metabolic profiles of tumours and paired normal tissues were similar when compared with normal mucosa, suggesting a potential field effect in gastric carcinogenesis. A total of 58 metabolites were identified, of which 44.8% comprising peptides, amino acids, and their derivatives showed marked upregulation in tumours, indicating enhanced amino acid metabolism. Elevated uracil and uridine levels suggested altered pyrimidine metabolism, reflecting increased nucleotide turnover and supporting rapid DNA/RNA synthesis. Pathway analysis highlighted modulation ofarginine biosynthesis, serine–one carbon metabolism, and nucleotide metabolism in gastric cancer tissues. ROC analysis identified ornithine and citrulline as potential discriminators in gastric cancer.  \nInterpretation and conclusions: Our findings reveal differentially altered metabolites in gastric cancer that are predominantly involved in arginine, serine one-carbon, and nucleotide metabolism. Ornithine and citrulline were identified as potential diagnostic biomarkers and therapeutic targets.  \nKeywords Arginine biosynthesis; Field cancerisation; Gastric cancer; LC-MS analysis; Metabolomic profiling; Pyrimidine metabolism  \nGastric cancer ranks fifth among the most frequently diagnosed cancers worldwide and seventh in India. 1,2 The principal diagnostic approach for gastric carcinoma involves esophagogastroduodenoscopy, followed by biopsy and histopathological examination. Serum biomarkers- carcinoembryonic antigen and carbohydrate antigen 19-9 (CA 19-9) are mainly used for monitoring recurrence; however, none are specific for diagnosis of gastric cancer.3 Most patients present with advanced-stage disease, resulting in poor survival outcomes and highlighting the urgent need for sensitive biomarkers for early detection and prevention of this disease.4,5  \nMetabolic rewiring is a hallmark of cancer, allowing malignant cells to alter their metabolism to meet elevated energy and biosynthetic demands during tumorigenesis.6 One of the earliest and most extensively studied features of cancer metabolism is the Warburg effect, described by Otto Warburg, in which cancer cells preferentially convert glucose to lactate, even under aerobic conditions.7 Metabolite profiling has diagnostic and predictive potential, including a 17-metabolite panel that distinguishes papillary thyroid carcinoma and predicts non-small cell lung Cancer treatment response.8,9 In gastric cancer, elevated lactate levels correlate with aggressiveness,  \nHow to cite this article: Rangarajan A, Natarajan T, Lakshminarayanan S, Sundersingh S, Subramani J, Gopisetty G. Targeted metabolomic profiling of gastric cancer bio","cbCaifRqNyUYYPAK","https://ap.wps.com/l/cbCaifRqNyUYYPAK","pdf",1261806,"English","# Background and objectives\n# Methods\n## Targeted metabolite profiling workflow\n# Results\n# Interpretation and conclusions","[{\"question\":\"What is the study’s main objective in gastric cancer research?\",\"answer\":\"To identify distinct metabolic alterations in gastric cancer biopsies using targeted metabolomic profiling and evaluate potential biomarkers and affected pathways.\"},{\"question\":\"How were metabolites analyzed in this research?\",\"answer\":\"Metabolites were profiled using liquid chromatography–mass spectrometry (LC–MS), followed by pathway enrichment, univariate analysis, and ROC curve assessment with MetaboAnalyst 6.0.\"},{\"question\":\"Which metabolites are highlighted as potential diagnostic biomarkers?\",\"answer\":\"Ornithine and citrulline are identified as potential discriminators for distinguishing gastric cancer.\"}]","Targeted metabolomic profiling of gastric cancer biopsies | PDF",1790103329,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2de140f040e098fbf9228a923f45fa53.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c49e57d9e990175cd6071886b45916e3.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bf2447b1c1c079764100849637c1171.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4e63e0e0e53c2f2598909d5306b87bb.webp",980,1268]